Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06728293 · ClinicalTrials.gov registry record · NA
Effect of the HCC Liver-Link Intervention
A NA study of HCC and Racial Disparities, sponsored by Indiana University.
- Recruiting
- Registry status
- NA
- Development phase
- 40
- Enrollment target
- 2
- Study locations
NCT06728293 is a NA study of HCC and Racial Disparities that is actively recruiting participants, run by Indiana University. The registered enrollment target is 40 participants, below the 199-participant average among 13 other HCC trials with a reported enrollment target (80% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT06728293, a NA study of HCC and Racial Disparities, is actively recruiting participants, sponsored by Indiana University.
- RECRUITING
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
- 2
- Study locations
Study Summary
This study is a pilot, multi-center randomized controlled trial testing the HCC Liver-Link intervention, a culturally tailored, multi-level program designed to reduce racial disparities in hepatocellular carcinoma (HCC) care. The intervention combines: (1) patient education to improve HCC-related disease and treatment knowledge, (2) social needs and substance use screening with referral to social work and community resources, and (3) facilitated access to subspecialty cancer care through a multidisciplinary HCC tumor board. A total of 40 Black patients with Barcelona Clinic Liver Cancer (BCLC) stage 0, A, or downstaged B disease will be randomized to receive either the HCC Liver-Link intervention or usual care and followed for 6 months or until liver transplant waitlisting. Primary outcomes are time to receipt of curative therapies (liver transplantation or resection) and change in HCC-related knowledge. Findings will inform development of larger interventions to eliminate racial disparities in HCC outcomes.
Conditions Studied
Interventions
- OTHER Liver Link
Study Locations (2)
Indiana
- Indiana University School of Medicine - Indianapolis
Maryland
- Johns Hopkins University - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2025-06-10 |
| Est. Completion | 2026-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06728293
The ClinicalTrials.gov registry entry for NCT06728293 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 199-participant average among 13 other HCC trials with a reported enrollment target (80% lower). The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with HCC appearing as the primary indexed condition, and to 1 intervention - of which Liver Link is the first listed.
NCT06728293 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Indiana, Maryland.
Frequently Asked Questions
What is clinical trial NCT06728293 about?
NCT06728293 is a clinical study titled "Effect of the HCC Liver-Link Intervention". This study is a pilot, multi-center randomized controlled trial testing the HCC Liver-Link intervention, a culturally tailored, multi-level program designed to reduce racial disparities in hepatocellular carcinoma (HCC) care. The intervention combines: (1) patient education to improve HCC-related di...
What is the current status of trial NCT06728293?
This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2025-06-10. Estimated completion is 2026-06.
What conditions does trial NCT06728293 study?
This clinical trial studies the following conditions: HCC, Racial Disparities.
What interventions are being tested in trial NCT06728293?
The interventions under investigation include: Liver Link (OTHER).
Who is sponsoring clinical trial NCT06728293?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06728293 being conducted?
This trial has 2 study locations across Indiana, Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HCC
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
CEUS vs. AMRI for HCC Detection in Patients With Indeterminate Liver Nodules
RECRUITING · NA
-
Evaluation of Liver Cancer With Magnetic Resonance Imaging (MRI)
COMPLETED · NA
-
Multi-analyte Blood Test Clinical Trial
RECRUITING
-
HOPE Against Cancer Recurrence in HCC
RECRUITING · Phase 4
-
REGULUS: MRI-guided Adaptive SABR for Liver Cancers
RECRUITING · Phase 2
-
Y-90 Treatment Response Using Transarterial Radioembolization
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.